Delivery Order SPE2DB20D1100-SPE2DB25FZ91E
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,065.93 firm fixed-price contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a completion date of December 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a ceiling value of $3,595.76 and a performance period ending on December 21, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a broader Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $2,483.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product.
The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a ceiling value of $2,770.34 and a performance period through August 30, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,960.12, is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medication used for the treatment of hypoglycemia. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,892.43 for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML pharmaceutical products. The contract has an ultimate completion date of June 11, 2024 and is a Firm Fixed Price arrangement.
The award is issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML pharmaceutical products. The potential value of this contract is $1,549.15, with a completion date of January 16, 2024. This delivery order is part of Amerisourcebergen Drug Corp's role as a prime contractor providing pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medication used for the treatment of hypoglycemia. The contract has a firm fixed price of $3,909.80 and an ultimate completion date of August 14, 2024. This contract is not designated as a set-aside and is an open competition award....
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for $999,999,999. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific award is for 4,558,478,916 units of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for 4,563,323,699 units of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, with a potential value of $1,236.72 and a completion date of January 16, 2024. The contract has no set-aside designation. AmerisourceBergen Drug Corp, through its...